Alcobra Company Profile (NASDAQ:ADHD)

About Alcobra

Alcobra logoAlcobra Ltd is an Israel-based Biopharmaceutical company. It focuses on the development and commercialization of a proprietary drug, MG01CI, to treat Attention Deficit Hyperactivity Disorder (ADHD), a common and morbid neuropsychiatric condition in children and adults. Adult ADHD is associated with increased health risks and healthcare costs, higher divorce rates, lower levels of socioeconomic attainment, lower academic achievement, unemployment and work place deficits, increased risks for motor vehicle accidents, greater likelihood of additional psychiatric disorders, increased criminal activity and incarceration, and higher rates of substance use and abuse. MG01CI product has completed phase two studies.

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: Biotechnology
  • Sub-Industry: N/A
  • Exchange: NASDAQ
  • Symbol: ADHD
  • CUSIP:
Key Metrics:
  • Previous Close: $2.37
  • 50 Day Moving Average: $3.76
  • 200 Day Moving Average: $4.37
  • 52-Week Range: $1.95 - $8.78
  • Trailing P/E Ratio: N/A
  • Foreward P/E Ratio: -2.29
  • P/E Growth: 0.00
  • Market Cap: $64.22M
  • Outstanding Shares: 27,562,000
  • Beta: 1.33
  • Return on Equity: -34.95%
  • Return on Assets: -33.50%
  • Current Ratio: 18.74%
  • Quick Ratio: 18.74%
Additional Links:
Companies Related to Alcobra:

Analyst Ratings

Consensus Ratings for Alcobra (NASDAQ:ADHD) (?)
Ratings Breakdown: 1 Sell Rating, 5 Hold Ratings, 4 Buy Ratings
Consensus Rating:Hold (Score: 2.30)
Consensus Price Target: $6.71 (186.94% upside)

Analysts' Ratings History for Alcobra (NASDAQ:ADHD)
DateFirmActionRatingPrice TargetDetails
10/7/2016Stifel NicolausDowngradeBuy -> HoldView Rating Details
10/3/2016Jefferies GroupReiterated RatingBuy$9.00 -> $6.00View Rating Details
10/1/2016Roth CapitalSet Price TargetBuy$8.00View Rating Details
9/29/2016Piper Jaffray Cos.DowngradeOverweight -> Neutral$10.00 -> $3.00View Rating Details
9/29/2016Oppenheimer Holdings Inc.DowngradeOutperform -> Market PerformView Rating Details
9/29/2016Cantor FitzgeraldDowngradeBuy -> Hold$2.00View Rating Details
9/12/2016WBB SecuritiesDowngradeHold -> Sell$5.00 -> $4.00View Rating Details
9/1/2016Goldman Sachs Group Inc.Reiterated RatingBuyView Rating Details
8/1/2016Barclays PLCInitiated CoverageEqual Weight$8.00View Rating Details
6/7/2016Canaccord GenuityInitiated CoverageBuyView Rating Details
11/17/2014AegisDowngradeBuy -> HoldView Rating Details
10/23/2014FBR & CoDowngradeOutperform -> Market Perform$22.00 -> $4.00View Rating Details
(Data available from 10/20/2014 forward)


Earnings History for Alcobra (NASDAQ:ADHD)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
8/30/2016Q216($0.22)($0.21)ViewListenView Earnings Details
5/16/2016Q116($0.22)($0.18)ViewListenView Earnings Details
2/17/2016Q415($0.24)($0.20)ViewListenView Earnings Details
11/17/2015Q315($0.31)($0.20)ViewN/AView Earnings Details
8/13/2015Q215($0.30)($0.24)ViewListenView Earnings Details
5/6/2015($0.31)($0.26)ViewN/AView Earnings Details
2/12/2015Q4($0.57)($0.50)ViewN/AView Earnings Details
11/17/2014Q3 14($0.56)($0.77)ViewN/AView Earnings Details
8/11/2014Q2($0.57)($0.57)ViewListenView Earnings Details
5/15/2014Q114($0.57)ViewN/AView Earnings Details
2/13/2014Q413($0.35)($0.45)ViewN/AView Earnings Details
11/7/2013Q313($0.28)ViewN/AView Earnings Details
8/6/2013Q213($0.06)($0.15)ViewN/AView Earnings Details
(Data available from 1/1/2011 forward)


Earnings Estimates for Alcobra (NASDAQ:ADHD)
Current Year EPS Consensus Estimate: $-0.94 EPS
Next Year EPS Consensus Estimate: $-1.02 EPS
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20163($0.19)($0.15)($0.17)
Q2 20163($0.22)($0.20)($0.21)
Q3 20163($0.29)($0.25)($0.27)
Q4 20163($0.34)($0.14)($0.27)
Q1 20171($0.12)($0.12)($0.12)
Q2 20171($0.12)($0.12)($0.12)
Q3 20171($0.13)($0.13)($0.13)
Q4 20171($0.14)($0.14)($0.14)
(Data provided by Zacks Investment Research)


Dividend History for Alcobra (NASDAQ:ADHD)
No dividend announcements for this company have been tracked by

Insider Trades

Insider Trading History for Alcobra (NASDAQ:ADHD)
No insider trades for this company have been tracked by


Latest Headlines for Alcobra (NASDAQ:ADHD)
News IconPrepping for a Big Move? Share Update on Alcobra Ltd. (NASDAQ:ADHD) - Yankee Analysts (NASDAQ:ADHD) - October 20 at 3:18 PM
News IconPrice Target Watch on Alcobra Ltd. (NASDAQ:ADHD) - Recall News (NASDAQ:ADHD) - October 19 at 3:44 PM
News IconMaking Waves: Penny Stock Update on Alcobra Ltd. (NASDAQ:ADHD) - Duncan Research (NASDAQ:ADHD) - October 19 at 3:44 PM
News IconPenny Stock Making News: Investors Looking Closely at Alcobra Ltd. (NASDAQ:ADHD) - Duncan Research (NASDAQ:ADHD) - October 18 at 3:18 PM
News IconPenny Stock in the News: A Closer Look at Alcobra Ltd. (NASDAQ:ADHD) - Duncan Research (NASDAQ:ADHD) - October 18 at 8:04 AM
News IconAlcobra Ltd. (ADHD) Updated Broker Ratings - NewsDen (NASDAQ:ADHD) - October 18 at 8:04 AM
News IconShare Value Diminishing Over Past Month: Alcobra Ltd. (NASDAQ:ADHD) - CSZ News (NASDAQ:ADHD) - October 16 at 8:05 AM
News IconBroker Changes For Alcobra Ltd. (ADHD) - NewsDen (NASDAQ:ADHD) - October 15 at 8:05 AM
News IconPenny Stock in Focus, Zeroing in on Alcobra Ltd. (NASDAQ:ADHD) - Duncan Research (NASDAQ:ADHD) - October 14 at 3:18 PM
News IconUnder the Microscope: Penny Stock Update Alcobra Ltd. (NASDAQ:ADHD) - Duncan Research (NASDAQ:ADHD) - October 12 at 8:39 PM
News IconAlcobra Ltd. (ADHD) Analyst Review - NewsDen (NASDAQ:ADHD) - October 12 at 3:31 PM
News IconPenny Stock in the News: Investors Looking at Alcobra Ltd. (NASDAQ:ADHD) - Duncan Research (NASDAQ:ADHD) - October 11 at 8:23 PM
News IconAlcobra updates details of FDA hold on Metadoxine for ADHD (NASDAQ:ADHD) - October 11 at 3:20 PM logoAlcobra Ltd. (ADHD) Receives Written Full Clinical Hold from FDA on MDX Phase 3 - (NASDAQ:ADHD) - October 7 at 3:18 PM logoUpdate from Alcobra on Recent FDA Communications (NASDAQ:ADHD) - October 7 at 3:18 PM
News IconBroker Roundup For Alcobra Ltd. (ADHD) - The De Soto Edge (NASDAQ:ADHD) - October 7 at 8:06 AM
News IconNews review of 2 biotech stocks: Alcobra (NASDAQ:ADHD), Arrowhead Pharmaceuticals (NASDAQ:ARWR) - The Voice Registrar (NASDAQ:ADHD) - October 3 at 3:17 PM
News IconNew Analyst Ratings On Alcobra Ltd. (ADHD) - NewsDen (NASDAQ:ADHD) - October 2 at 3:18 PM
News IconAlcobra Ltd. (NASDAQ:ADHD) Sale Analysis - Newburgh Press (NASDAQ:ADHD) - October 1 at 8:42 AM
News IconCatching the Wonder of Investors: Alcobra Ltd. (NASDAQ:ADHD) - Duncan Research (NASDAQ:ADHD) - September 30 at 3:45 PM logo[video]Alcobra (ADHD) Stock Sliding, Downgraded After FDA Clinical Hold (NASDAQ:ADHD) - September 30 at 3:45 PM logoUnusual 11 Mid-Day Movers 9/29: (ITCI) (ADHD) (MRNS) Higher; (CATB) (AEGR) (DRNA) Lower - (NASDAQ:ADHD) - September 29 at 3:17 PM logoAnalysts Chime in on Two Volatile Biotech Stocks: Catabasis Pharmaceuticals Inc (CATB), Alcobra Ltd (ADHD) - Smarter Analyst (NASDAQ:ADHD) - September 29 at 3:17 PM logo12 Biggest Mid-Day Losers For Thursday - Benzinga (NASDAQ:ADHD) - September 29 at 3:17 PM logoAlcobra Pharma downgraded by Cantor Fitzgerald (NASDAQ:ADHD) - September 29 at 3:17 PM logoAlcobra (ADHD) Stock Tumbles on FDA Clinical Hold, Cantor Remains Bullish (NASDAQ:ADHD) - September 29 at 3:17 PM logoAlcobra Tumbles on FDA Clinical Hold (NASDAQ:ADHD) - September 29 at 3:17 PM logoHere’s Why These Five Stocks Are in the Spotlight Today (NASDAQ:ADHD) - September 29 at 3:17 PM logoADHD Doesn't MEASURE Up, AMGN ARISEs To The Occasion, ITCI Misses Study Goal - RTT News (NASDAQ:ADHD) - September 29 at 8:04 AM logoAlcobra Ltd. (ADHD) Reports Full Clinical Hold on IND Applications for MDX and Phase III MEASURE Study - (NASDAQ:ADHD) - September 29 at 8:04 AM logoAlcobra Announces IND Clinical Hold Affecting the MDX Phase III MEASURE Study (NASDAQ:ADHD) - September 29 at 8:04 AM logo2:57 am Alcobra Pharma receives notice of clinical hold from FDA for co's MDX Phase III MEASURE study (NASDAQ:ADHD) - September 29 at 8:04 AM
News IconLatest Analyst Reports On Alcobra Ltd. - NewsDen (NASDAQ:ADHD) - September 28 at 3:17 PM
News IconEarnings According to Analysts for Alcobra Ltd. (NASDAQ:ADHD)? - Frisco Fastball (NASDAQ:ADHD) - September 20 at 3:18 PM
News IconHodgkin Lymphoma (B-Cell Hodgkin Lymphoma) Pipeline Market H2 2016 Global Review Research (NASDAQ:ADHD) - September 19 at 8:03 AM
News IconAlcobra Limited Ord (NASDAQ:ADHD) Shorts Decreased by 0.85% After Short Covering - Frisco Fastball (NASDAQ:ADHD) - September 14 at 3:19 PM
News IconAlcobra Ltd. (ADHD) Cut to “Sell” at WBB Securities - National Daily Press (NASDAQ:ADHD) - September 13 at 8:05 AM
News IconStock Falling Lower in Trade: Alcobra Ltd. (NASDAQ:ADHD) - Post News (NASDAQ:ADHD) - September 12 at 3:18 PM
News IconAlcobra Ltd. (NASDAQ:ADHD): How Are Analysts Advising to Play This Stock? - Post News (NASDAQ:ADHD) - September 12 at 8:05 AM
News IconNoticeable Earnings Watch: Alcobra Ltd (NASDAQ:ADHD) - Post Registrar (NASDAQ:ADHD) - August 31 at 3:19 PM logoEdited Transcript of ADHD earnings conference call or presentation 30-Aug-16 12:30pm GMT (NASDAQ:ADHD) - August 31 at 8:04 AM logoCan Shares Of Alcobra Ltd. (NASDAQ:ADHD) Get To $17? - Investor Newswire (NASDAQ:ADHD) - August 30 at 3:18 PM logoCompany Earnings Report Before Market Opens (NASDAQ:ADHD) - August 30 at 12:20 PM logoAlcobra reports 2Q loss (NASDAQ:ADHD) - August 30 at 12:20 PM logoAlcobra Announces Second Quarter 2016 Financial Results and Provides Corporate Update (NASDAQ:ADHD) - August 30 at 12:20 PM logoAlcobra Ltd. (NASDAQ:ADHD) Gets 0 Recommendations To Sell - Investor Newswire (NASDAQ:ADHD) - August 23 at 9:32 AM
News IconSell-side Price Target Review on Alcobra Ltd. (NASDAQ:ADHD) - Post News (NASDAQ:ADHD) - August 22 at 8:05 AM logoWill Alcobra Ltd. (NASDAQ:ADHD) Hit $17 Price Target? - Investor Newswire (NASDAQ:ADHD) - August 16 at 3:19 PM logoAlcobra Ltd. to Release Second Quarter Financial Results and Host Corporate Update Conference Call & Webcast on Tuesday, August 30 (NASDAQ:ADHD) - August 15 at 10:33 AM logoIs a Surprise Coming for Alcobra (ADHD) This Earnings Season? (NASDAQ:ADHD) - August 9 at 12:03 PM


Alcobra (NASDAQ:ADHD) Chart for Thursday, October, 20, 2016

Last Updated on 10/20/2016 by Staff